IFP Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-118
Closed -$19K 4636
2022
Q4
$19K Sell
118
-43
-27% -$14.3K ﹤0.01% 2950
2022
Q3
$19K Buy
161
+5
+3% +$1.35K ﹤0.01% 3157
2022
Q2
$18K Hold
156
﹤0.01% 2973
2022
Q1
$18K Buy
156
+149
+2,129% +$45.9K ﹤0.01% 2973
2021
Q4
$3K Hold
7
﹤0.01% 2719
2021
Q3
$3K Sell
7
-4
-36% -$1.35K ﹤0.01% 2785
2021
Q2
$3K Hold
11
﹤0.01% 2688
2021
Q1
$4K Sell
11
-10
-48% -$3.2K ﹤0.01% 2518
2020
Q4
$7K Sell
21
-3,307
-99% -$915K ﹤0.01% 2218
2020
Q3
$914K Buy
3,328
+3,317
+30,155% +$956K 0.05% 308
2020
Q2
$2K Sell
11
-61
-85% -$12.2K ﹤0.01% 2450
2020
Q1
$11K Buy
72
+22
+44% +$3.65K ﹤0.01% 1744
2019
Q4
$8K Buy
50
+3
+6% +$556 ﹤0.01% 2038
2019
Q3
$8K Buy
+47
New +$10.2K ﹤0.01% 2193
2019
Q1
$64K Sell
221
-942
-81% -$313K 0.01% 868
2018
Q4
$370K Buy
1,163
+221
+23% +$76.8K 0.02% 643
2018
Q3
$424K Buy
942
+508
+117% +$200K 0.02% 744
2018
Q2
$178K Buy
434
+97
+29% +$35.1K 0.01% 1130
2018
Q1
$63K Hold
337
﹤0.01% 1680
2017
Q4
$63K Buy
337
+169
+101% +$31.6K ﹤0.01% 1697
2017
Q3
$28K Sell
168
-300
-64% -$45.4K ﹤0.01% 2397
2017
Q2
$67K Buy
468
+366
+359% +$49.2K ﹤0.01% 1776
2017
Q1
$13K Buy
+102
New +$11.8K ﹤0.01% 2787
2016
Q4
Sell
-1,295
Closed -$167K 4191
2016
Q3
$167K Buy
1,295
+748
+137% +$89.6K 0.01% 1092
2016
Q2
$60K Buy
547
+326
+148% +$32.4K ﹤0.01% 1662
2016
Q1
$64K Buy
221
+201
+1,005% +$17K 0.01% 868
2015
Q4
$2K Buy
+20
New +$1.7K ﹤0.01% 3393

Other funds holding ABMD

IFP Advisors's ABMD Position: Q1 2023 in Review

IFP Advisors sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 118 shares — an estimated $19K sold.

IFP Advisors first reported a position in ABMD in Q4 2015 and held it in 27 quarters. The position peaked at $914K in Q3 2020. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.

  • IFP Advisors reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 118 Abiomed Inc shares in Q1 2023, an estimated $19K.
  • IFP Advisors first reported a position in Abiomed Inc in Q4 2015 and held it in 27 quarters.
  • IFP Advisors's Abiomed Inc position peaked at $914K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.